Profil
Gregory Weiss is the founder of PhageTech, Inc. (founded in 2014) and Debut Biotechnology, Inc. (founded in 2019).
Postes actifs de Gregory Weiss
| Sociétés | Poste | Début |
|---|---|---|
PhageTech, Inc.
 PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA. | Fondateur | 01/01/2014 |
Anciens postes connus de Gregory Weiss
| Sociétés | Poste | Fin |
|---|---|---|
Debut Biotechnology, Inc.
 Debut Biotechnology, Inc. BiotechnologyHealth Technology Debut Biotechnology, Inc. engages in the manufacture of high value molecules by combining custom designed immobilized enzymes with continuous biomanufacturing processes. The firm's cell-free platform has the ability to transform low-value bio-renewable materials into high value therapeutics and specialty chemicals. The company was founded by Joshua Britton, Brady Beauchamp, and Gregory Weiss and is headquartered in San Diego, CA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
PhageTech, Inc.
PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA. | Commercial Services |
Debut Biotechnology, Inc.
Debut Biotechnology, Inc. BiotechnologyHealth Technology Debut Biotechnology, Inc. engages in the manufacture of high value molecules by combining custom designed immobilized enzymes with continuous biomanufacturing processes. The firm's cell-free platform has the ability to transform low-value bio-renewable materials into high value therapeutics and specialty chemicals. The company was founded by Joshua Britton, Brady Beauchamp, and Gregory Weiss and is headquartered in San Diego, CA. | Health Technology |
